Takeover

Acquirers

BioTime, Inc.

Targets
1
Filings
1
Median premium
49%
First filing
Feb 4, 2019
Latest filing
Feb 4, 2019

Targets

CompanyScore before dealScore nowFilingsLatest
Asterias Biotherapeutics, Inc.——1Feb 4, 2019

Deal filings

FiledCompanyFormPricePremium
Feb 4, 2019Asterias Biotherapeutics, Inc.DEFM14A$0.7149.25%